A New Horizon in Liver Disease

M Kudo - Oncology, 2017 - karger.com
Hagiwara et al.[1] describe the outcome of combination therapy with sofosbuvir and
ledipasvir for those with chronic viral type C liver disease. They conclude that a favorable …
相关文章
[PDF] academia.edu

[PDF][PDF] A New Horizon in Liver Disease

M Kudo - Oncology, 2017 - academia.edu
Yada et al.[2] describe the influence of liver inflammation on measurements of liver stiffness
in patients with autoimmune hepatitis. They conclude that the simultaneous use of shear …

[引用][C] A New Horizon in Liver Disease

M Kudo - Oncology, 2017 - pubmed.ncbi.nlm.nih.gov

[引用][C] A New Horizon in Liver Disease.

M Kudo - Oncology, 2016 - europepmc.org
A New Horizon in Liver Disease. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter …

A New Horizon in Liver Disease

M Kudo - Oncology, 2017 - karger.com
Yada et al.[2] describe the influence of liver inflammation on measurements of liver stiffness
in patients with autoimmune hepatitis. They conclude that the simultaneous use of shear …
[PDF] archive.org

[PDF][PDF] A New Horizon in Liver Disease

M Kudo - Oncology, 2017 - scholar.archive.org
Yada et al.[2] describe the influence of liver inflammation on measurements of liver stiffness
in patients with autoimmune hepatitis. They conclude that the simultaneous use of shear …

A New Horizon in Liver Disease.

M Kudo - Oncology, 2017 - go.gale.com
Hagiwara et al.[1] describe the outcome of combination therapy with sofosbuvir and
ledipasvir for those with chronic viral type C liver disease. They conclude that a favorable …